Authors:
Ticchioni, M
Raimondi, V
Lamy, L
Wijdenes, J
Lindberg, FP
Brown, EJ
Bernard, A
Citation: M. Ticchioni et al., Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow, FASEB J, 15(2), 2001, pp. 341-350
Authors:
Ragnarsson, L
Stromberg, T
Wijdenes, J
Totterman, TH
Weigelt, C
Citation: L. Ragnarsson et al., Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells, CANCER IMMU, 50(7), 2001, pp. 382-390
Authors:
Bernard, J
Treton, D
Vermot-Desroches, C
Boden, C
Horellou, P
Angevin, E
Galanaud, P
Wijdenes, J
Richard, Y
Citation: J. Bernard et al., Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13R alpha 2 as a decoy receptor for IL13, LAB INV, 81(9), 2001, pp. 1223-1231
Authors:
Haddad, E
Paczesny, S
Leblond, V
Seigneurin, JM
Stern, M
Achkar, A
Bauwens, M
Delwail, V
Debray, D
Duvoux, C
Hubert, P
de Ligny, BH
Wijdenes, J
Durandy, A
Fischer, A
Citation: E. Haddad et al., Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial, BLOOD, 97(6), 2001, pp. 1590-1597
Authors:
Corbi, P
Rahmati, M
Delwail, A
Potreau, D
Menu, P
Wijdenes, J
Lecron, JC
Citation: P. Corbi et al., Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation, EUR J CAR-T, 18(1), 2000, pp. 98-103
Authors:
Gu, ZJ
De Vos, J
Rebouissou, C
Jourdan, M
Zhang, XG
Rossi, JF
Wijdenes, J
Klein, B
Citation: Zj. Gu et al., Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cellsurvival and growth factors, LEUKEMIA, 14(1), 2000, pp. 188-197
Authors:
Hammacher, A
Wijdenes, J
Hilton, DJ
Nicola, NA
Simpson, RJ
Layton, JE
Citation: A. Hammacher et al., Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors, BIOCHEM J, 345, 2000, pp. 25-32
Authors:
Yi, FH
Lautrette, C
Vermot-Desroches, C
Bordessoule, D
Couratier, P
Wijdenes, J
Preud'homme, JL
Jauberteau, MO
Citation: Fh. Yi et al., In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients, J NEUROIMM, 109(2), 2000, pp. 211-220
Authors:
Muller-Newen, G
Kuster, A
Wijdenes, J
Schaper, F
Heinrich, PC
Citation: G. Muller-newen et al., Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies, J BIOL CHEM, 275(7), 2000, pp. 4579-4586
Authors:
Moreau, P
Harousseau, JL
Wijdenes, J
Morineau, N
Milpied, N
Bataille, R
Citation: P. Moreau et al., A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma, BR J HAEM, 109(3), 2000, pp. 661-664
Authors:
Llorente, L
Richaud-Patin, Y
Garcia-Padilla, C
Claret, E
Jakez-Ocampo, J
Cardiel, MH
Alcocer-Varela, J
Grangeot-Keros, L
Alarcon-Segovia, D
Wijdenes, J
Galanaud, P
Emilie, D
Citation: L. Llorente et al., Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus, ARTH RHEUM, 43(8), 2000, pp. 1790-1800
Authors:
Foussat, A
Wijdenes, J
Bouchet, L
Gaidano, G
Neipel, F
Balabanian, K
Galanaud, P
Couderc, J
Emilie, D
Citation: A. Foussat et al., Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes, EUR CYTOKIN, 10(4), 1999, pp. 501-508
Authors:
Couturier, O
Faivre-Chauvet, A
Filippovich, IV
Thedrez, P
Sai-Maurel, C
Bardies, M
Mishra, AK
Gauvrit, M
Blain, G
Apostolidis, C
Molinet, R
Abbe, JC
Bataille, R
Wijdenes, J
Chatal, JF
Cherel, M
Citation: O. Couturier et al., Validation of Bi-213-alpha radioimmunotherapy for multiple myeloma, CLIN CANC R, 5(10), 1999, pp. 3165S-3170S
Authors:
Le Meur, Y
Lorgeot, V
Aldigier, JC
Wijdenes, J
Leroux-Robert, C
Praloran, V
Citation: Y. Le Meur et al., Whole blood production of monocytic cytokines (IL-1 beta, IL-6, TNF-alpha,sIL-6R, IL-1Ra) in haemodialysed patients, NEPH DIAL T, 14(10), 1999, pp. 2420-2426
Authors:
Foussat, A
Fior, R
Girard, T
Boue, F
Wijdenes, J
Galanaud, P
Emilie, D
Citation: A. Foussat et al., Involvement of human interleukin-6 in systemic manifestations of human herpesvirus type 8-associated multicentric Castleman's disease, AIDS, 13(1), 1999, pp. 150-152
Authors:
Frieling, JTM
van Hamersvelt, HW
Wijdenes, J
Hendriks, T
Sauerwein, RW
van der Linden, CJ
Citation: Jtm. Frieling et al., Circulating concentrations of soluble interleukin 6 receptors gp80 and gp130 in chronic renal failure and effects of renal replacement therapy, AM J NEPHR, 19(5), 1999, pp. 571-575
Authors:
Tartour, E
Fossiez, F
Joyeux, I
Galinha, A
Gey, A
Claret, E
Sastre-Garau, X
Couturier, J
Mosseri, V
Vives, V
Banchereau, J
Fridman, WH
Wijdenes, J
Lebecque, S
Sautes-Fridman, C
Citation: E. Tartour et al., Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice, CANCER RES, 59(15), 1999, pp. 3698-3704
Authors:
Lelievre, E
Sarrouilhe, D
Morel, F
Preud'Homme, JL
Wijdenes, J
Lecron, JC
Citation: E. Lelievre et al., Preincubation of human resting T cell clones with interleukin 10 strongly enhances their ability to produce cytokines after stimulation, CYTOKINE, 10(11), 1998, pp. 831-840
Authors:
Azimzadeh, A
Romain, N
Vermot-Desroches, C
Ravanat, C
Chenard, MP
Wijdenes, J
Herve, P
Jaeck, D
Wolf, P
Citation: A. Azimzadeh et al., Antibodies to human adhesion molecules and von Willebrand factor: In vitrocross-species reactivity in the xenotransplantation setting, XENOTRANSPL, 5(4), 1998, pp. 284-291